We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Brii, which plans to combine partnerships, R&D and digital/big data, will use WuXi AppTec and WuXi biologics for development of its projects, rather than building its own facilities.
The 2016 Novel Drugs Summary issued by the U.S. Food & Drug Administration (FDA) shows that FDA approved 22 new molecular entities (NDE) in total by the end of December 2016.